Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.

Carella, A M; Pollicardo, N; Pungolino, E; Frassoni, F; Giordano, D; Bruni, R; Spriano, M; Rossi, E

Carella, A M; Pollicardo, N; Pungolino, E; Frassoni, F; Giordano, D; Bruni, R; Spriano, M; Rossi, E.

Affiliation

Carella AM; Hematology and Autografting Unit, Ospedale S. Martino, Genoa, Italy.

Leuk Lymphoma ; 15 Suppl 1: 59-61, 1995.

Article in En | MEDLINE | ID: mdl-7539318

Subject(s)

Hematopoietic Stem Cell Transplantation; Hodgkin Disease/therapy; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Bleomycin/administration & dosage; Dacarbazine/administration & dosage; Doxorubicin/administration & dosage; Female; Follow-Up Studies; Hodgkin Disease/mortality; Humans; Male; Mechlorethamine/administration & dosage; Middle Aged; Prednisone/administration & dosage; Procarbazine/administration & dosage; Retrospective Studies; Survival Rate; Transplantation, Autologous; Vinblastine; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1995 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links